BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 10210772)

  • 1. Interleukin-6 receptor signaling. I. gp80 and gp130 receptor interaction in the absence of interleukin-6.
    Gaillard JP; Mani JC; Liautard J; Klein B; Brochier J
    Eur Cytokine Netw; 1999 Mar; 10(1):43-8. PubMed ID: 10210772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses.
    Müller-Newen G; Küster A; Hemmann U; Keul R; Horsten U; Martens A; Graeve L; Wijdenes J; Heinrich PC
    J Immunol; 1998 Dec; 161(11):6347-55. PubMed ID: 9834125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-6 receptor signaling. II. Bio-availability of interleukin-6 in serum.
    Gaillard J; Pugnière M; Tresca J; Mani J; Klein B; Brochier J
    Eur Cytokine Netw; 1999 Sep; 10(3):337-44. PubMed ID: 10477390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The N-terminus of gp130 is critical for the formation of the high-affinity interleukin-6 receptor complex.
    Moritz RL; Ward LD; Tu GF; Fabri LJ; Ji H; Yasukawa K; Simpson RJ
    Growth Factors; 1999; 16(4):265-78. PubMed ID: 10427501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of soluble gp130 released by melanoma cell lines: A polyvalent antagonist of cytokines from the interleukin 6 family.
    Montero-Julian FA; Brailly H; Sautès C; Joyeux I; Dorval T; Mosseri V; Yasukawa K; Wijdenes J; Adler A; Gorin I; Fridman WH; Tartour E
    Clin Cancer Res; 1997 Aug; 3(8):1443-51. PubMed ID: 9815830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The soluble IL-6 receptors: serum levels and biological function.
    Montero-Julian FA
    Cell Mol Biol (Noisy-le-grand); 2001 Jun; 47(4):583-97. PubMed ID: 11502067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Soluble IL-6 receptors].
    Jabłońska E
    Postepy Hig Med Dosw; 1998; 52(2):133-8. PubMed ID: 9640977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of IL-6 and the soluble IL-6 receptor in inhibition of VCAM-1 gene expression.
    Oh JW; Van Wagoner NJ; Rose-John S; Benveniste EN
    J Immunol; 1998 Nov; 161(9):4992-9. PubMed ID: 9794436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific inhibition of IL-6 signalling with monoclonal antibodies against the gp130 receptor.
    Liautard J; Sun RX; Cotte N; Gaillard JP; Mani JC; Klein B; Brochier J
    Cytokine; 1997 Apr; 9(4):233-41. PubMed ID: 9112331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel path to activation of vascular smooth muscle cells: up-regulation of gp130 creates an autocrine activation loop by IL-6 and its soluble receptor.
    Klouche M; Bhakdi S; Hemmes M; Rose-John S
    J Immunol; 1999 Oct; 163(8):4583-9. PubMed ID: 10510402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer.
    Rose-John S; Scheller J; Elson G; Jones SA
    J Leukoc Biol; 2006 Aug; 80(2):227-36. PubMed ID: 16707558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of soluble interleukin 6 receptor and soluble gp130 are elevated in patients with localized scleroderma.
    Nagaoka T; Sato S; Hasegawa M; Ihn H; Takehara K
    J Rheumatol; 2000 Aug; 27(8):1917-21. PubMed ID: 10955333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo and in vitro activities of the gp130-stimulating designer cytokine Hyper-IL-6.
    Peters M; Blinn G; Solem F; Fischer M; Meyer zum Büschenfelde KH; Rose-John S
    J Immunol; 1998 Oct; 161(7):3575-81. PubMed ID: 9759879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating interleukin-6 family cytokines and their receptors in patients with congestive heart failure.
    Hirota H; Izumi M; Hamaguchi T; Sugiyama S; Murakami E; Kunisada K; Fujio Y; Oshima Y; Nakaoka Y; Yamauchi-Takihara K
    Heart Vessels; 2004 Sep; 19(5):237-41. PubMed ID: 15372299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endotoxin down-regulates monocyte and granulocyte interleukin-6 receptors without influencing gp130 expression in humans.
    Dekkers PE; Juffermans NP; ten Hove T; de Jonge E; van Deventer SJ; van der Poll T
    J Infect Dis; 2000 Mar; 181(3):1055-61. PubMed ID: 10720531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a monoclonal antibody-based enzyme-linked immunoabsorbent assay for the binding of gp130 to the IL-6/IL-6R complex and its competitive inhibition.
    Scheller J; Kovaleva M; Rabe B; Eichler J; Kallen KJ; Rose-John S
    J Immunol Methods; 2004 Aug; 291(1-2):93-100. PubMed ID: 15345308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Determination of serum soluble interleukin-6 receptor and soluble gp130 levels in patient with pregnancy induced hypertension and its significance].
    Li Y; Wang Y; Qi L
    Zhonghua Fu Chan Ke Za Zhi; 2001 Jan; 36(1):18-9. PubMed ID: 11778537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signal through gp130 activated by soluble interleukin (IL)-6 receptor (R) and IL-6 or IL-6R/IL-6 fusion protein enhances ex vivo expansion of human peripheral blood-derived hematopoietic progenitors.
    Kimura T; Wang J; Minamiguchi H; Fujiki H; Harada S; Okuda K; Kaneko H; Yokota S; Yasukawa K; Abe T; Sonoda Y
    Stem Cells; 2000; 18(6):444-52. PubMed ID: 11072033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profile of soluble cytokine receptors in Crohn's disease.
    Gustot T; Lemmers A; Louis E; Nicaise C; Quertinmont E; Belaiche J; Roland S; Van Gossum A; Devière J; Franchimont D
    Gut; 2005 Apr; 54(4):488-95. PubMed ID: 15753533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of gp130/interleukin-6 receptor transducing component in interleukin-11 receptor.
    Fourcin M; Chevalier S; Lebrun JJ; Kelly P; Pouplard A; Wijdenes J; Gascan H
    Eur J Immunol; 1994 Jan; 24(1):277-80. PubMed ID: 8020567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.